Juvena Therapeutics

Employees
11–50
Business Model
B2B
Last Round
SAFEJan 2026
Rounds
3

About

Computationally-driven biopharmaceutical company engineering secreted protein biologics to treat myopathies and metabolic diseases.

Summary

Juvena Therapeutics is an Artificial Intelligence company based in Redwood City, United States. Its most recent funding was a SAFE round in Jan 2026. Investors include Bison Ventures, Mubadala Capital and Jefferson Life Sciences.

Tech & App Stack

2 technologies & apps tracked

Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

Series BSeries BJan 2026

Sign up to see all 3 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies